DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) insider James P. Shaughnessy sold 1,800 shares of DocuSign stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $57.50, for a total value of $103,500.00. Following the completion of the sale, the insider now directly owns 46,503 shares of the company's stock, valued at $2,673,922.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
DocuSign Trading Up 3.3 %
NASDAQ:DOCU opened at $60.55 on Thursday. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $64.76. The stock has a market cap of $12.44 billion, a price-to-earnings ratio of 168.20, a PEG ratio of 5.09 and a beta of 0.89. The stock has a 50-day moving average price of $55.66 and a two-hundred day moving average price of $50.76.
DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.06. The firm had revenue of $712.39 million during the quarter, compared to analysts' expectations of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. Sell-side analysts forecast that DocuSign, Inc. will post 0.86 earnings per share for the current year.
Analyst Ratings Changes
The Best AI Stock to Own in the World Today is Trading for Just $25
From Banyan Hill Publishing | Ad
“Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him
A number of equities research analysts recently commented on DOCU shares. TheStreet raised DocuSign from a "d+" rating to a "c-" rating in a research note on Tuesday, December 19th. Morgan Stanley raised DocuSign from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $49.00 to $64.00 in a research note on Tuesday, January 16th. Piper Sandler decreased their price objective on DocuSign from $57.00 to $50.00 and set a "neutral" rating for the company in a research note on Friday, December 8th. Wells Fargo & Company decreased their price objective on DocuSign from $55.00 to $45.00 and set an "underweight" rating for the company in a research note on Monday, February 5th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $84.00 price objective on shares of DocuSign in a research note on Monday, January 22nd. Three analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, DocuSign has a consensus rating of "Hold" and a consensus target price of $58.33.
Get Our Latest Report on DocuSign
Institutional Trading of DocuSign
Institutional investors have recently modified their holdings of the company. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its holdings in shares of DocuSign by 440.0% in the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company's stock valued at $28,000 after purchasing an additional 220 shares in the last quarter. Capital Analysts LLC lifted its holdings in shares of DocuSign by 781.7% in the fourth quarter. Capital Analysts LLC now owns 529 shares of the company's stock valued at $31,000 after purchasing an additional 469 shares in the last quarter. BluePath Capital Management LLC bought a new stake in shares of DocuSign in the third quarter valued at about $32,000. McGlone Suttner Wealth Management Inc. bought a new stake in shares of DocuSign in the fourth quarter valued at about $32,000. Finally, Virtus Fund Advisers LLC bought a new stake in shares of DocuSign in the fourth quarter valued at about $33,000. 77.64% of the stock is currently owned by institutional investors.
DocuSign Company Profile
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
